Message Pharmaceuticals, Inc.
Records under this name other than patents Message Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Message Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,153,882 | Agents Useful for Reducing Amyloid Precursor Protein and Treating Demantia and Methods of Use Thereof Formerly held Term ended Term ended Dec 23, 2022 · High confidence | Term ended | Term ended Dec 23, 2022 | High confidence |
| US 6,465,176 | Method for identifying compounds RNA/RNA binding protein interactions Lapsed on the fee record Ended Oct 15, 2014 · From the USPTO record | Lapsed on the fee record | Ended Oct 15, 2014 | From the USPTO record |
| US 6,448,007 | Functional genomic screen for post-transcriptional 5′ and 3′ regulatory elements Lapsed on the fee record Ended Sep 10, 2014 · From the USPTO record | Lapsed on the fee record | Ended Sep 10, 2014 | From the USPTO record |
| US 7,078,171 | Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation Lapsed on the fee record Ended Jul 18, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jul 18, 2014 | From the USPTO record |
| US 7,037,660 | Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids Lapsed on the fee record Ended May 2, 2014 · From the USPTO record | Lapsed on the fee record | Ended May 2, 2014 | From the USPTO record |
| US 6,107,029 | Universal method for detecting interactions between RNA molecules and RNA binding proteins Lapsed on the fee record Ended Aug 22, 2012 · From the USPTO record | Lapsed on the fee record | Ended Aug 22, 2012 | From the USPTO record |
| US 7,001,924 | Inhibitors of RNase P proteins as antibacterial compounds Lapsed on the fee record Ended Feb 21, 2010 · From the USPTO record | Lapsed on the fee record | Ended Feb 21, 2010 | From the USPTO record |
| US 6,936,432 | Novel Bacterial Rnase P Proteins and Their Use in Identifying Antibacterial Compounds Lapsed on the fee record Ended Aug 30, 2009 · Medium confidence | Lapsed on the fee record | Ended Aug 30, 2009 | Medium confidence |
| US 6,872,850 | Small molecule inhibitors of secretion of proteins encoded by ARE-mRNAs Lapsed on the fee record Ended Mar 29, 2009 · From the USPTO record | Lapsed on the fee record | Ended Mar 29, 2009 | From the USPTO record |
| US 6,630,589 | Identification of compounds for the treatment or prevention of proliferative diseases Lapsed on the fee record Ended Oct 7, 2007 · From the USPTO record | Lapsed on the fee record | Ended Oct 7, 2007 | From the USPTO record |